TG Therapeutics Tops Q2 EPS by 21c QA

  • Investing.com
TG Therapeutics Tops Q2 EPS by 21c QA

TG Therapeutics (NASDAQ: TGTX ) reported Q2 EPS of ($0.30), $0.21 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $594 thousand versus the consensus estimate of $175.43 thousand.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles